Identifying driver mutations involves a combination of computational and experimental approaches. Whole genome sequencing and comparative genomics are used to pinpoint recurrent mutations in cancer genomes. Functional assays, such as gene knockout and overexpression studies, help validate the impact of these mutations on cellular behavior.